Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 208.78M | 204.73M | 185.74M | 192.44M | 219.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 208.78M | 204.73M | 185.74M | 192.44M | 219.83M |
| Cost of Revenue | 134.23M | 143.06M | 150.05M | 151.90M | 152.71M |
| Gross Profit | 74.55M | 61.67M | 35.69M | 40.54M | 67.12M |
| SG&A Expenses | 126.94M | 132.53M | 143.01M | 153.87M | 157.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 276.39M | 292.00M | 310.46M | 323.94M | 329.31M |
| Operating Income | -67.62M | -87.27M | -124.72M | -131.50M | -109.48M |
| Income Before Tax | -136.49M | -188.81M | -234.97M | -218.04M | -345.03M |
| Income Tax Expenses | -408.00K | -4.53M | -4.21M | -4.23M | -3.82M |
| Earnings from Continuing Operations | -136.08 | -184.29 | -230.76 | -213.81 | -341.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 58.69M | 79.73M | 99.99M | 92.82M | 148.70M |
| Net Income | -77.39M | -104.56M | -130.77M | -121.00M | -192.52M |
| EBIT | -67.62M | -87.27M | -124.72M | -131.50M | -109.48M |
| EBITDA | -18.83M | -37.11M | -73.21M | -80.07M | -59.29M |
| EPS Basic | -0.53 | -0.72 | -0.91 | -0.84 | -1.35 |
| Normalized Basic EPS | 0.04 | 0.09 | 0.07 | -0.02 | 0.46 |
| EPS Diluted | -0.53 | -0.72 | -0.91 | -0.84 | -1.35 |
| Normalized Diluted EPS | 0.04 | 0.09 | 0.07 | -0.02 | 0.46 |
| Average Basic Shares Outstanding | 584.18M | 580.42M | 577.42M | 574.16M | 571.03M |
| Average Diluted Shares Outstanding | 584.18M | 580.42M | 577.42M | 574.16M | 571.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |